Behbahani Ali bought BDTX
September 18, 2026 · Form 4 insider transaction
Behbahani Ali bought 7,707 shares of Black Diamond Therapeutics, Inc. at $1.93 per share, a transaction worth $14.9K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,707
Price
$1.93
Total value
$14.9K
InsiderBehbahani Ali
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateSeptember 18, 2026
Filing dateSeptember 21, 2026
Shares owned after110,236
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were issued in accordance with the Issuer's Sixth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.; The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 17, 2026.